2nd Mar 2010 12:48
2 March 2010
Cyprotex PLC
("Cyprotex" or the "Company")
Rule 2.10 Announcement
Pursuant to Rule 2.10 of the City Code on Mergers and Acquisitions (the "Code"), Cyprotex confirms that it has 178,957,188 ordinary shares of 0.1p each ("Ordinary Shares"), in issue and admitted to trading on the AIM market of the London Stock Exchange. The International Securities Identification Number for the ordinary shares is GB0031214470.
Rule 19.11 disclosure
In accordance with Rule 19.11 of the Code, a copy of this Announcement will be published on the Cyprotex website: www.cyprotex.com.
|
Enquiries:
Cyprotex PLC |
|
|
||
|
Anthony Baxter CEO |
01625 505 100 |
|
||
|
www.cyprotex.com |
|
|||
|
Execution Noble & Company Limited |
|
|
||
|
John Llewellyn-Lloyd |
020 7456 9191 |
|
||
|
Sam Reynolds |
|
|
||
|
|
|
|
||
|
Public Relations |
|
|
||
|
Financial Dynamics |
|
|
||
|
Ben Brewerton |
020 7831 3113 |
|
||
|
Ben Atwell |
|
|
||
|
John Dineen |
|
|
||
|
|
|
|
||
Related Shares:
CRX.L